Screener
CorMedix CRMD Finance Lease Liabilities
Discontinued — last reported Q4 '25
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The source filing: CorMedix’s 10-K, filed March 5, 2026.
- Filed
- Mar 5, 2026, 8:32 AM EST
- Fiscal year
- FY2025
- Accession
- 0001213900-26-023889
| Line item | December 31, 2025 | December 31, 2024 |
|---|---|---|
| Convertible senior notes, net of deferred financing costs | 144,626 | - |
| Contingent Consideration, net of current portion | 99,101 | - |
| Operating lease liabilities, net of current | 2,253 | 349 |
| Finance lease liabilities, net of current | 586 | - |
| TOTAL LIABILITIES | 420,835 | 34,189 |
| COMMITMENTS AND CONTINGENCIES (Note 9) | ||
| STOCKHOLDERS’ EQUITY | ||
| Preferred stock - $0.001 par value: 2,000,000 shares authorized; 91,623 and 136,623 shares issued and outstanding at December 31, 2025 and 2024, respectively | - | - |
Item 16. Form 10-K Summary
FAQ
- What is CorMedix's finance lease liabilities?
- CorMedix (CRMD) reported finance lease liabilities of $586K in Q4 2025.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about CorMedix's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude